Overview

Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether AM-111 is effective in the treatment of acute inner ear hearing loss (acute sensorineural hearing loss, ASNHL).
Phase:
Phase 2
Details
Lead Sponsor:
Auris Medical AG